Publications and Research Notes
KEI publishes research and commentary in a variety of journals, periodicals, books and other independent publishing platforms. In-house, KEI publishes the open journal Knowledge Ecology Studies, and presents information in blogs, correspondence and reports, as well as in occasional KEI research notes and papers.
KEI Policy and Briefing Notes
2015:1 KEI TPP Briefing Note: Compulsory licenses on patents and the 3-step test.
2014:1 KEI Policy Brief: Nonvoluntary use of patents for drugs to treat the Hepatitis C Virus in the United States: Mechanisms available to the Federal Government, State Governments and Private Actors. July 18, 2014
KEI Research Notes
2014:1 KEI Research Note: Recent European Union Compulsory Licenses. March 1, 2014
2014:2 KEI Research Note: Recent United States Compulsory Licenses. March 7, 2014
2014:3 KEI Research Note: Elizabeth Rajasingh, Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results. 17 November 2014
2011:2 KEI Research Note: Tedmund Wan. Survey of drug prices for 14 drugs with US government rights in patents listed in the FDA Orange Book.
2011:1. KEI Research Note: Paul Miano. Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines.
2010:5 KEI Research Note: James Love. Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region.
2010:4 KEI Research Note: Anne Mira Guha, Prices for Abbott's Norvir (generic name Ritonavir) as a Standalone Product in 2010.
2010:3 KEI Research Note: Molly Redfield Ward, Notes on the 2004 to 2009 United States Food and Drug Administration Approval of New Molecular Entities (NMEs).
2010:2 KEI Research Note: Public and Private Sector Funded Research in Fabry's Disease.
2010:1 KEI Research Note: James Love, Comments on ACTA Provisions on Injunctions and Damages.
2008:3 KEI Research Note: Jacqueline Lee, Research and Development Related to dasatinib (Sprycel-tm).
2008:2 KEI Research Note: An Annotated Bibliography of Scholarly and Technical Articles and Books on Innovation Prizes.
2008:1 KEI Research Note: Selected Innovation Prizes and Reward Programs.
2007:6 KEI Research Note: David Serafino. Survey of Patent Pools Demonstrates Variety of Purposes and Management Structures.
2007:5 KEI Research Note: James Love. Compulsory licensing of copyright under Article 44.2 of the TRIPS, in light of eBay.
2007:4 KEI Research Note: Judit Rius. Organización Mundial de la Salud -- Grupo de Trabajo Intergubernamental sobre Salud Pública, Innovación y Propiedad Intelectual (IGWG).
2007:3 KEI Research Note: IGWG Briefing Paper on Patent Pools.
2007:2 KEI Research Note: James Love. Recent examples of the use of compulsory licenses on patents.
KEI Research Papers
2007:1. James Love and Tim Hubbard The Big Idea: Prizes to Stimulate R&D for New Medicines.
2006:1. Judit Rius Sanjuan, James Love and Robert Weissman, Protection of Pharmaceutical Test Data: A Policy Proposal.